Devonian Health Group welcomes Ashish Chabria and Luc Gregoire to its Board of Directors

– CANADA, Quebec City –  Devonian Health Group Inc. (TSX: GSD | OTC: DVHGF), a clinical-stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, today announced the elections of Ashish Chabria and Luc Gregoire to its Board of Directors as new members, at the AGM.

‘‘We welcome our two newest board members Ashish Chabria and Luc Gregoire to the Team and take this opportunity to thank our three departing members Sybil Dahan, Denis Poirier and Martin Moreau for their valuable contributions and wish them the very best in their future endeavors,’’ said CEO, Pierre Montanaro.

About Devonian

Devonian Health Group Inc. is a late-stage botanical pharmaceutical corporation with novel therapeutic approaches to targeting unmet medical needs. Devonian’s core strategy is to develop prescription botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases including but not limited to ulcerative colitis and atopic dermatitis. Based on a foundation of over 15 years of research, Devonian’s focus is further supported by a US-FDA set of regulatory guidelines favoring a more efficient drug development pathway for prescription botanical drug products over those of traditional prescription medicines.

Devonian is also involved in the development of high-value cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.